Basilea Pharmaceutica
Basel
About Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the integrated research, development and commercial operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd., the company focuses on providing innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology, targeting the medical challenge of rising resistance and nonresponse to current treatment options.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $100K – $500K
- Total funding: $191.0M
- Funding stage: IPO
- Last round: Grant (Feb 2026)
- Ticker: swx:BSLN
- Website: basilea.com
- Phone: 41616061112
Industries & Categories
Biotechnology, Commercial, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/basilea-pharmaceutica-21233 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.